Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RALBAT: Raltegravir Switch for Bone Mineral Density in HIV-positive Women
NCT01902186Phase 4Terminated
- Start
- Sep 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in osteopenia. Started Sep 2014; status: terminated.
02
Drugs
raltegravir
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT01902186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01902186.